中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [3]
自动化研究所 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2023 [1]
2020 [1]
2019 [1]
2015 [1]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis
期刊论文
OAI收割
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 卷号: 15
作者:
Wang, Jingwen
;
Zhang, Lijie
;
Wang, Minghe
;
Zhang, Jing
;
Wang, Yaqi
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2023/11/10
locally advanced rectal cancer
neoadjuvant chemoradiotherapy
organ preservation
total neoadjuvant therapy
watch-and-wait
Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Yang, Yang
;
Xu, Xiaofang
;
Zhou, Xia
;
Bao, Wuan
;
Zhang, Danhong
  |  
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2020/10/26
esophageal cancer
neoadjuvant chemoradiotherapy
surgery
radiation dose
trimodality cancer treatment
Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer
期刊论文
OAI收割
RADIOTHERAPY AND ONCOLOGY, 2019, 卷号: 132, 页码: 100-108
作者:
Tang, Zhenchao
;
Zhang, Xiao-Yan
;
Liu, Zhenyu
;
Li, Xiao-Ting
;
Shi, Yan-Jie
  |  
收藏
  |  
浏览/下载:67/0
  |  
提交时间:2019/07/12
Locally advanced rectal cancer
Neoadjuvant chemoradiotherapy
Organ-preserving strategies
Diffusion weighted imaging
Decision support
Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
期刊论文
OAI收割
CHINESE JOURNAL OF CANCER, 2015, 卷号: 34
-
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/10/26
PREOPERATIVE CHEMORADIATION
TUMOR RESPONSE
POSTOPERATIVE CHEMORADIOTHERAPY
MESORECTAL EXCISION
TRIAL
RADIOTHERAPY
RESECTION
INTERVAL
THERAPY
CAPECITABINE
Rectal cancer
Pathologic complete response
Neoadjuvant chemoradiotherapy
Carcinoembryonic antigen
Interval